Get the Stockscreener App
49.21
1.88%
0.91
Pre-market:
48.11
-1.10
-2.24%
Livanova Plc stock is traded at $49.21, with a volume of 316.43K.
It is up +1.88% in the last 24 hours and up +3.40% over the past month.
UK-based LivaNova was born of a combination between Cyberonics in the us and Sorin in Italy. The medical-device firm is primarily focused on cardiopulmonary solutions (with heart-lung machines and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, LivaNova divested its cardiac rhythm management and heart valve businesses. It derives roughly half of its revenue from the us market, another 21% from Europe, and the remainder from the rest of the world.
See More
Previous Close:
$48.30
Open:
$48.68
24h Volume:
316.43K
Relative Volume:
0.67
Market Cap:
$2.67B
Revenue:
$1.24B
Net Income/Loss:
$23.68M
P/E Ratio:
117.17
EPS:
0.42
Net Cash Flow:
$108.67M
1W Performance:
+3.32%
1M Performance:
+3.40%
6M Performance:
-6.99%
1Y Performance:
-2.07%
1-Day Range:
$48.41
$49.26
1-Week Range:
$47.23
$49.26
52-Week Range:
$43.15
$64.47
Livanova Plc Stock (LIVN) Company Profile
Name
Livanova Plc
Sector
Industry
Phone
4402033250662
Address
20 EASTBOURNE TERRACE, LONDON
Compare LIVN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LIVN
Livanova Plc
|
49.21 | 2.67B | 1.24B | 23.68M | 108.67M | 0.42 |
|
ABT
Abbott Laboratories
|
116.79 | 201.01B | 41.22B | 5.77B | 6.49B | 3.29 |
|
SYK
Stryker Corp
|
395.85 | 150.90B | 21.97B | 3.59B | 3.21B | 9.33 |
|
BSX
Boston Scientific Corp
|
100.91 | 148.72B | 15.91B | 1.79B | 1.89B | 1.21 |
|
MDT
Medtronic Plc
|
88.38 | 113.33B | 33.00B | 4.29B | 5.50B | 3.27 |
|
EW
Edwards Lifesciences Corp
|
69.97 | 41.27B | 6.60B | 4.16B | 490.10M | 6.93 |
Livanova Plc Stock (LIVN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-04-24 | Initiated | Goldman | Buy |
| Sep-17-24 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Mar-20-24 | Reiterated | Needham | Buy |
| Feb-20-24 | Upgrade | Mizuho | Neutral → Buy |
| Sep-06-23 | Initiated | HSBC Securities | Hold |
| Jul-19-23 | Initiated | Robert W. Baird | Neutral |
| Apr-14-23 | Initiated | Mizuho | Neutral |
| Dec-21-22 | Initiated | Barclays | Equal Weight |
| Apr-06-22 | Initiated | Wolfe Research | Outperform |
| Feb-24-22 | Upgrade | UBS | Neutral → Buy |
| Dec-03-21 | Initiated | Goldman | Buy |
| Aug-20-21 | Reiterated | Needham | Buy |
| Jul-20-21 | Upgrade | Needham | Hold → Buy |
| Mar-03-21 | Downgrade | Berenberg | Buy → Hold |
| Jan-05-21 | Downgrade | Needham | Buy → Hold |
| Sep-02-20 | Initiated | Robert W. Baird | Outperform |
| Jun-26-20 | Reiterated | Needham | Buy |
| Oct-30-19 | Reiterated | Needham | Buy |
| Feb-28-19 | Reiterated | Needham | Buy |
| Nov-28-18 | Initiated | UBS | Neutral |
| Aug-02-18 | Reiterated | Needham | Buy |
| Jun-08-18 | Initiated | Stifel | Buy |
| May-31-18 | Reiterated | Needham | Buy |
| Feb-28-18 | Reiterated | Needham | Buy |
View All
Livanova Plc Stock (LIVN) Latest News
LivaNova PLC (NASDAQ:LIVN) Receives Average Recommendation of "Buy" from Brokerages - MarketBeat
LivaNova Sets Date for Q4 and Full-Year 2024 Earnings Release and Conference Call - StockTitan
LivaNova to Announce Fourth-Quarter and Full-Year 2024 Results - The Bakersfield Californian
LivaNova's OSPREY Sleep Apnea Trail on aura6000 Meets Primary Endpoint - MSN
LIVN (LivaNova) EV-to-EBITDA : 53.85 (As of Jan. 20, 2025) - GuruFocus.com
Vagus Nerve Stimulators Market Growth in Future Scope 2025-2032 - openPR
StockNews.com Upgrades LivaNova (NASDAQ:LIVN) to Strong-Buy - MarketBeat
42,185 Shares in LivaNova PLC (NASDAQ:LIVN) Purchased by Harbor Capital Advisors Inc. - MarketBeat
Nordea Investment Management AB Acquires 12,470 Shares of LivaNova PLC (NASDAQ:LIVN) - MarketBeat
LivaNova PLC appoints Natalia Kozmina as Chief Human Resources Officer - ETHRWorld Middle East
LivaNova Appoints Natalia Kozmina as Chief Human Resources Officer - Business Wire
Electroceuticals Market Top Companies StudyMedtronic Plc - openPR
Principal Financial Group Inc. Has $9.01 Million Position in LivaNova PLC (NASDAQ:LIVN) - MarketBeat
LivaNova Becomes Oversold (LIVN) - Nasdaq
LivaNova PLC's (NASDAQ:LIVN) Price Is Right But Growth Is Lacking - Simply Wall St
LivaNova PLC (NASDAQ:LIVN) Receives Consensus Rating of "Buy" from Analysts - MarketBeat
(LIVN) Investment Report - Stock Traders Daily
LivaNova (NASDAQ:LIVN) Lowered to Buy Rating by StockNews.com - MarketBeat
Vagus Nerve Stimulators Market Growth in Future Scope 2024-2031 - openPR
Vagus Nerve Stimulators Market Report Analysis and Research - openPR
LivaNova's Depression Treatment Study Shows Promise Despite Mixed Clinical Results - StockTitan
RECOVER Clinical Study Shows Meaningful Benefits of LivaNova’s VNS Therapy System in Select Secondary Endpoints for Unipolar Patients with Treatment-Resistant Depression - Business Wire
StockNews.com Upgrades LivaNova (NASDAQ:LIVN) to "Strong-Buy" - MarketBeat
State Street Corp Cuts Stake in LivaNova PLC (NASDAQ:LIVN) - MarketBeat
Fmr LLC Has $1.65 Million Stock Position in LivaNova PLC (NASDAQ:LIVN) - MarketBeat
When (LIVN) Moves Investors should Listen - Stock Traders Daily
LivaNova's SWOT analysis: sleep apnea platform could awaken stock potential - Investing.com India
Jane Street Group LLC Sells 19,525 Shares of LivaNova PLC (NASDAQ:LIVN) - MarketBeat
LivaNova PLC (NASDAQ:LIVN) Shares Sold by Barclays PLC - MarketBeat
XTX Topco Ltd Invests $550,000 in LivaNova PLC (NASDAQ:LIVN) - MarketBeat
Insider Sell: Francesco Bianchi Sells 1,250 Shares of LivaNova P - GuruFocus.com
Key Factors Shaping the Medical Implants Market: Trends - openPR
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Acquires 58,807 Shares of LivaNova PLC (NASDAQ:LIVN) - MarketBeat
Implantable Cardiac Monitors Market Analyzing CAGR 5.13% - openPR
Cardiac Resynchronization Therapy (CRT) Market Insights, Competitive Landscape and Market Forecast 2024-2030 - GlobeNewswire Inc.
BNP Paribas Financial Markets Reduces Holdings in LivaNova PLC (NASDAQ:LIVN) - MarketBeat
Cerity Partners LLC Invests $573,000 in LivaNova PLC (NASDAQ:LIVN) - MarketBeat
Holocene Advisors LP Raises Stake in LivaNova PLC (NASDAQ:LIVN) - MarketBeat
Polar Asset Management Partners Inc. Buys New Position in LivaNova PLC (NASDAQ:LIVN) - MarketBeat
Pacemakers Market to Witness Massive Growth with Medtronic, LivaNova, Medico - openPR
LivaNova to Present Scientific Data at American Epilepsy Society 2024 Annual Meeting - sharewise
Redmile Group LLC Sells 54,467 Shares of LivaNova PLC (NASDAQ:LIVN) - MarketBeat
Cardiac Rhythm Management Devices Market: Holistic Growth - openPR
Thrivent Financial for Lutherans Has $670,000 Stock Position in LivaNova PLC (NASDAQ:LIVN) - MarketBeat
LivaNova to Present Breakthrough Epilepsy Treatment Research at Major AES 2024 Conference - StockTitan
Parkman Healthcare Partners LLC Grows Stake in LivaNova PLC (NASDAQ:LIVN) - MarketBeat
NFJ Investment Group LLC Has $5.07 Million Stock Holdings in LivaNova PLC (NASDAQ:LIVN) - MarketBeat
LivaNova PLC (NASDAQ:LIVN) Shares Bought by Charles Schwab Investment Management Inc. - MarketBeat
11,735 Shares in LivaNova PLC (NASDAQ:LIVN) Acquired by Martingale Asset Management L P - MarketBeat
LivaNova PLC (NASDAQ:LIVN) Shares Purchased by The Manufacturers Life Insurance Company - MarketBeat
LivaNova PLC (NASDAQ:LIVN) Receives $69.17 Consensus Target Price from Analysts - MarketBeat
Livanova Plc Stock (LIVN) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.55%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):